321 related articles for article (PubMed ID: 22482472)
1. How do drugs get their brand names?
Novack GD
Ocul Surf; 2012 Apr; 10(2):117-20. PubMed ID: 22482472
[No Abstract] [Full Text] [Related]
2. PLIVA v. Mensing: generic consumers' unfortunate hand.
Lee SB
Yale J Health Policy Law Ethics; 2012; 12(2):209-63. PubMed ID: 23175916
[No Abstract] [Full Text] [Related]
3. Lawsuits anticipated on generic biologicals front.
Fox JL
Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
[No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: FDA oversight.
Chaps NA
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
[No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: FDA oversight.
; Berry MD
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-86. PubMed ID: 22403845
[No Abstract] [Full Text] [Related]
6. Cosmetology, cosmetics, cosmeceuticals: definitions and regulations.
Millikan LE
Clin Dermatol; 2001; 19(4):371-4. PubMed ID: 11535376
[No Abstract] [Full Text] [Related]
7. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
[No Abstract] [Full Text] [Related]
8. Generic drugs: the stalling game.
Consum Rep; 2001 Jul; 66(7):36-40. PubMed ID: 11725791
[TBL] [Abstract][Full Text] [Related]
9. Generics battle brand names over mortality of drug patents.
Betz R
J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008
[No Abstract] [Full Text] [Related]
10. I understand the Food and Drug Administration doesn't regulate dietary supplements as it does prescription drugs. What do I look for when shopping for vitamins and supplements?
Mayo Clin Health Lett; 2010 Dec; 28(12):8. PubMed ID: 21229659
[No Abstract] [Full Text] [Related]
11. Branded drug reformulation: the next brand vs. generic antitrust battleground.
Amoresano GV
Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032
[No Abstract] [Full Text] [Related]
12. Biogenerics standoff.
Herrera S
Nat Biotechnol; 2004 Nov; 22(11):1343-6. PubMed ID: 15529145
[No Abstract] [Full Text] [Related]
13. Dietary supplements: background for dialogue between the industry and the medical profession.
Friede AI
Food Drug Law J; 1998; 53(3):413-20. PubMed ID: 10346719
[No Abstract] [Full Text] [Related]
14. Pharmaceuticals and medical devices: cost savings.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
[No Abstract] [Full Text] [Related]
15. Fifty years of cosmetic safety: a government and industry partnership.
Donegan TJ
Food Drug Law J; 1995; 50 Spec():151-62. PubMed ID: 10343040
[No Abstract] [Full Text] [Related]
16. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers.
Soehnge H
Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584
[No Abstract] [Full Text] [Related]
17. Drugs, codes, standards, and other incompatible things in the dark.
Chute CG
MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386
[No Abstract] [Full Text] [Related]
18. Medication errors caused by confusion of drug names.
Hoffman JM; Proulx SM
Drug Saf; 2003; 26(7):445-52. PubMed ID: 12735783
[TBL] [Abstract][Full Text] [Related]
19. Drug names and medication errors: who is responsible?
LeBelle MJ
CMAJ; 1993 Oct; 149(7):941-3. PubMed ID: 8402422
[No Abstract] [Full Text] [Related]
20. Old drugs, new uses: solving a Hatch-Waxman patent predicament.
McPhie DC
Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
